15
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
Leveraging Data-Driven Patient Participation to Accelerate Medical Research
The fuel for biomedical innovation is data.
podcast episode
Ep. 50: Special Edition — Potential Breakthroughs in COVID-19 Research Coming From Cancer Research
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther
Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understa
+ Read More
podcast episode
Ep. 49: Time Equals Lives, with FasterCures’ Esther Krofah
“We spend numerous hours a day updating that tracker because what is critical is real-time informa
tion that researchers and scientists can respond to....As I've been speaking to colleagues, ranging from NIH to these large companies, they're usin
+ Read More
podcast episode
Ep. 47: Unprecedented, with UCLA Health’s John Mazziotta
“One day, for the first time in my 39 years, there were no patients in the emergency department. I
t was a Sunday morning.
+ Read More
podcast episode
Ep. 44: The Virus and the Clock, with Moderna’s Tal Zaks
“In this fight, where we are today—this is May of 2020—there's a lot of other companies and a lot
of other approaches that are trying to generate vaccines. I wish them all success, and we all need to be successful here.
+ Read More
podcast episode
Ep. 36: The Pioneer, with the National Cancer Institute’s Steven Rosenberg
“We're perhaps working now at 10% of where we were working before the COVID infections.
podcast episode
Ep. 54: In Translation, with NCATS’ Christopher Austin
“Are we going to require the same level of evidence for a vaccine...before it is approved? Could w
e potentially begin to use it at the same time we're still studying it?
+ Read More
podcast episode
Ep. 55: Test and Isolate, with Nobel Laureate Paul Romer
“The fundamental decision that every society has to make is, can we suppress this virus forever if
necessary? Can we afford to do that?...If you know that you're going to give up, there's no point to suppress for a while.”
+ Read More
video
Ep. 50: Special Edition - Potential Breakthroughs in COVID-19 Research Coming From Cancer Research
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther
Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understanding an
+ Read More
article
Incarcerated People Can’t Get Left Behind in COVID-19 Protections
,
This pandemic is altering the shape of our society as we know it, and we face a humanitarian cris
is if we don’t act swiftly to protect those behind bars and the staff who work every day in this environment.
,
+ Read More
article
A Diseased Nation: COVID-19 as a Deadly Symptom of Systemic Racism in the US
,
During and in the aftermath of this pandemic, there is an opportunity to look at our current poli
cies and systems and identify ways to reverse the impacts of structural and systemic racism.,
+ Read More